Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis
- PMID: 35501407
- DOI: 10.1038/s41380-022-01591-x
Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis
Erratum in
-
Correction: Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis.Mol Psychiatry. 2022 Sep;27(9):3617-3618. doi: 10.1038/s41380-022-01620-9. Mol Psychiatry. 2022. PMID: 35624147 No abstract available.
-
Correction: Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis.Mol Psychiatry. 2023 May;28(5):2170. doi: 10.1038/s41380-023-01983-7. Mol Psychiatry. 2023. PMID: 36759546 No abstract available.
Abstract
Introduction: The retina shares structural and functional similarities with the brain. Furthermore, structural changes in the retina have been observed in patients with schizophrenia spectrum disorders (SSDs). This systematic review and meta-analysis investigated retinal abnormalities and their association with clinical factors for SSD.
Methods: Studies related to retinal layers in SSD patients were retrieved from PubMed, Scopus, Web of Science, Cochrane Controlled Register of Trials, International Clinical Trials Registry Platform, and PSYNDEX databases from inception to March 31, 2021. We screened and assessed the eligibility of the identified studies. EZR ver.1.54 and the metafor package in R were used for the meta-analysis and a random-effects or fixed-effects model was used to report standardized mean differences (SMDs).
Results: Twenty-three studies (2079 eyes of patients and 1571 eyes of controls) were included in the systematic review and meta-analysis. The average peripapillary retinal nerve fiber layer (pRNFL) thickness, average macular thickness (MT), and macular ganglion cell layer-inner plexiform layer (GCL-IPL) thickness were significantly lower in patients than in controls (n = 14, 6, and 3, respectively; SMD = -0.33, -0.49, and -0.43, respectively). Patients also had significantly reduced macular volume (MV) compared to controls (n = 7; SMD = -0.53). The optic cup volume (OCV) was significantly larger in patients than in controls (n = 3; SMD = 0.28). The meta-regression analysis indicated an association between several clinical factors, such as duration of illness and the effect size of the pRNFL, macular GCL-IPL, MT, and MV.
Conclusion: Thinning of the pRNFL, macular GCL-IPL, MT, and MV and enlargement of the OCV in SSD were observed. Retinal abnormalities may be applicable as state/trait markers in SSDs. The accumulated evidence was mainly cross-sectional and requires verification by longitudinal studies to characterize the relationship between OCT findings and clinical factors.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Associations of refractive errors and retinal changes measured by optical coherence tomography: A systematic review and meta-analysis.Surv Ophthalmol. 2022 Mar-Apr;67(2):591-607. doi: 10.1016/j.survophthal.2021.07.007. Epub 2021 Jul 31. Surv Ophthalmol. 2022. PMID: 34343537
-
Ganglion Cell Layer Thickness as a Biomarker for Amyotrophic Lateral Sclerosis Functional Outcome: An OCT study.Rom J Ophthalmol. 2025 Apr-Jun;69(2):200-207. doi: 10.22336/rjo.2025.32. Rom J Ophthalmol. 2025. PMID: 40698100 Free PMC article.
-
The association between attention-deficit/hyperactivity disorder and retinal nerve fiber/ganglion cell layer thickness measured by optical coherence tomography: a systematic review and meta-analysis.Int Ophthalmol. 2021 Sep;41(9):3211-3221. doi: 10.1007/s10792-021-01852-8. Epub 2021 May 20. Int Ophthalmol. 2021. PMID: 34014463
-
Optical coherence tomography and angiography reveal early retinal alterations in pediatric-onset multiple sclerosis.Eur J Pediatr. 2025 Jun 6;184(7):398. doi: 10.1007/s00431-025-06234-1. Eur J Pediatr. 2025. PMID: 40478274
-
Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.Surv Ophthalmol. 2025 May-Jun;70(3):412-425. doi: 10.1016/j.survophthal.2025.01.002. Epub 2025 Jan 15. Surv Ophthalmol. 2025. PMID: 39824297
Cited by
-
Association Between Retinal Features From Multimodal Imaging and Schizophrenia.JAMA Psychiatry. 2023 May 1;80(5):478-487. doi: 10.1001/jamapsychiatry.2023.0171. JAMA Psychiatry. 2023. PMID: 36947045 Free PMC article.
-
Variations of retinal dysfunctions with the level of cannabis use in regular users: Toward a better understanding of cannabis use pathophysiology.Front Psychiatry. 2022 Nov 17;13:959347. doi: 10.3389/fpsyt.2022.959347. eCollection 2022. Front Psychiatry. 2022. PMID: 36465284 Free PMC article.
-
Specific association between retinal neural layer thinning and neurological soft signs in schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2024 Aug;274(5):1237-1240. doi: 10.1007/s00406-023-01742-3. Epub 2024 Jan 20. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38244078
-
Potential diagnostic biomarkers for schizophrenia.Med Rev (2021). 2022 Aug 2;2(4):385-416. doi: 10.1515/mr-2022-0009. eCollection 2022 Aug. Med Rev (2021). 2022. PMID: 37724326 Free PMC article. Review.
-
Retinal electrophysiology in central nervous system disorders. A review of human and mouse studies.Front Neurosci. 2023 Aug 2;17:1215097. doi: 10.3389/fnins.2023.1215097. eCollection 2023. Front Neurosci. 2023. PMID: 37600004 Free PMC article. Review.
References
-
- McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia—an overview. JAMA Psychiatry. 2020;77:201–10. - PubMed
-
- Davison J, O’Gorman A, Brennan L, Cotter DR. A systematic review of metabolite biomarkers of schizophrenia. Schizophr Res. 2018;195:32–50. - PubMed
-
- Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999;46:729–39. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous